Interstitial pneumonia NOS
Drug-induced interstitial lung disorders
Interstitial lung disease
Interstitial lung disease, drug induced
Interstitial pneumonia
A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of pulmonary alveoli that extends to the interstitium and beyond leading to diffuse pulmonary fibrosis. Interstitial lung diseases are classified by their etiology known or unknown causes), and radiological-pathological features.
Heterogeneous group of noninfectious, nonmalignant disorders of the lower respiratory tract, affecting primarily the alveolar wall structures but also often involving the small airways and blood vessels of the lung parenchyma; may lead to respiratory insufficiency and death.
Interstitial lung disease is the name for a large group of diseases that inflame or scar the lungs. The inflammation and scarring make it hard to get enough oxygen. The scarring is called pulmonary fibrosis.breathing in dust or other particles in the air are responsible for some types of interstitial lung diseases. Specific types include
J84.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
The 2023 edition of ICD-10-CM J84.9 became effective on October 1, 2022.
This is the American ICD-10-CM version of J84.9 – other international versions of ICD-10 J84.9 may differ.